DSM Q1 2016 results

Highlights

• DSM reports a strong first quarter
• Group net sales up at €1,913 million, with 2% organic growth
• Group EBITDA up 19% to €296 million
• Nutrition: 6% organic sales growth, EBITDA up 15%
• Materials: EBITDA up 10%, supported by low input costs
• Group ROCE: improved to 9.8% (Q1 2015: 6.8%) driven by EBIT growth
• Outlook maintained

Key figures and indicators (continuing operations)

CEO statement
Feike Sijbesma, CEO/Chairman of the DSM Managing Board, commented: "We are pleased to report that we delivered a strong first quarter in terms of growth, profitability and returns, with all businesses seeing the effects of our improvement programs.

Both Animal and Human Nutrition delivered above-market volume growth, with Human Nutrition showing a marked improvement, albeit against a relatively weak comparable quarter in 2015. Our efforts resulted in EBITDA growth and an improved margin in Nutrition. Materials remained robust, helped in part by the shift towards higher added-value products in the portfolio.
In addition, low input prices continued to support margins during Q1 2016 despite softer volumes in some segments, although we expect this support to diminish somewhat going forward.

While the macro-economic environment remains uncertain, we are confident that we will deliver in line with our medium-term goals. This will be supported by innovation, our growth initiatives and underpinned by our group-wide cost and productivity improvement programs."

Outlook 2016

Contact Information

Additional Information
Today DSM will hold a conference call for media from 08:00 to 08:30 and a conference call for investors and analysts from 09:00 to 10:00. Details on how to access these calls can be found on the DSM website, www.dsm.com.